Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity
Martin Siegemund(University of Stuttgart), Klaus Pfizenmaier(University of Stuttgart)
Cited by 67
Related Papers
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
|Frontiers in Cell and Developmental Biology|2020|240
A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death
|PLoS ONE|2011|126
Antitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein
|Frontiers in Immunology|2017|16
Pharmacokinetic Engineering of OX40-Blocking Anticalin Proteins Using Monomeric Plasma Half-Life Extension Domains
|Frontiers in Pharmacology|2021|11